Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Phase 4 Active not recruiting 136 enrolled Oregon Health and Science University

RandomizedParallel-groupSingle-blindPrevention

Summary

A two-arm randomized control trial evaluating rates of urinary tract infection in post-menopausal women on vaginal estrogen with recurrent urinary tract infections.

Timeline

Start: 2024-12-23
Primary completion: 2026-04
Completion: 2026-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Chlorhexidine	Small molecule	2 %	Topical

Chlorhexidine Lavage for Recurrent Urinary Tract Infection

Summary

Timeline

Drugs

Indications